• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性心肌病的类型:预后及影响因素——一项临床研究

Types of Septic Cardiomyopathy: Prognosis and Influencing Factors - A Clinical Study.

作者信息

Lu Nian-Fang, Niu Hong-Xia, Liu An-Qi, Chen Ya-Lei, Liu Hu-Nan, Zhao Pei-Hong, Shao Jun, Xi Xiu-Ming

机构信息

Department of Critical Care Medicine, Capital Medical University Electric Teaching Hospital/Beijing Electric Power Hospital, Beijing, People's Republic of China.

Department of Emergency, Capital Medical University Electric Teaching Hospital/Beijing Electric Power Hospital, Beijing, People's Republic of China.

出版信息

Risk Manag Healthc Policy. 2024 Apr 23;17:1015-1025. doi: 10.2147/RMHP.S452803. eCollection 2024.

DOI:10.2147/RMHP.S452803
PMID:38680475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11055516/
Abstract

OBJECTIVE

To explore the prognostic outcomes associated with different types of septic cardiomyopathy and analyze the factors that exert an influence on these outcomes.

METHODS

The data collected within 24 hours of ICU admission included cardiac troponin I (cTnI), N-terminal pro-Brain Natriuretic Peptide (NT-proBNP); SOFA (sequential organ failure assessment) scores, and the proportion of vasopressor use. Based on echocardiographic outcomes, septic cardiomyopathy was categorized into left ventricular (LV) systolic dysfunction, LV diastolic dysfunction, and right ventricular (RV) systolic dysfunction. Differences between the mortality and survival groups, as well as between each cardiomyopathy subgroup and the non-cardiomyopathy group were compared, to explore the influencing factors of cardiomyopathy.

RESULTS

A cohort of 184 patients were included in this study, with LV diastolic dysfunction having the highest incidence rate (43.5%). The mortality group had significantly higher SOFA scores, vasopressor use, and cTnI levels compared to the survival group; the survival group had better LV diastolic function than the mortality group ( < 0.05 for all). In contrast to the non-cardiomyopathy group, each subgroup within the cardiomyopathy category exhibited elevated levels of cTnI. The subgroup with left ventricular diastolic dysfunction demonstrated a higher prevalence of advanced age, hypertension, diabetes mellitus, coronary artery disease, and an increased mortality rate; the RV systolic dysfunction subgroup had higher SOFA scores and NT-proBNP levels, and a higher mortality rate ( < 0.05 for all); the LV systolic dysfunction subgroup had a similar mortality rate ( > 0.05).

CONCLUSION

Patients with advanced age, hypertension, diabetes mellitus, or coronary artery disease are more prone to develop LV diastolic dysfunction type of cardiomyopathy; cardiomyopathy subgroups had higher levels of cTnI. The RV systolic dysfunction cardiomyopathy subgroup had higher SOFA scores and NT-proBNP levels. The occurrence of RV systolic dysfunction in patients with sepsis significantly increased the mortality rate.

摘要

目的

探讨不同类型脓毒症性心肌病的预后结局,并分析影响这些结局的因素。

方法

收集入住重症监护病房(ICU)24小时内的数据,包括心肌肌钙蛋白I(cTnI)、N末端脑钠肽前体(NT-proBNP);序贯器官衰竭评估(SOFA)评分以及血管活性药物使用比例。根据超声心动图结果,将脓毒症性心肌病分为左心室(LV)收缩功能障碍、LV舒张功能障碍和右心室(RV)收缩功能障碍。比较死亡组和存活组之间以及各心肌病亚组与非心肌病组之间的差异,以探讨心肌病的影响因素。

结果

本研究纳入了184例患者,其中LV舒张功能障碍的发生率最高(43.5%)。与存活组相比,死亡组的SOFA评分、血管活性药物使用和cTnI水平显著更高;存活组的LV舒张功能优于死亡组(所有P<0.05)。与非心肌病组相比,心肌病类别中的每个亚组cTnI水平均升高。左心室舒张功能障碍亚组高龄、高血压、糖尿病、冠状动脉疾病的患病率更高,死亡率增加;RV收缩功能障碍亚组的SOFA评分和NT-proBNP水平更高,死亡率更高(所有P<0.05);LV收缩功能障碍亚组的死亡率相似(P>0.05)。

结论

高龄、高血压、糖尿病或冠状动脉疾病患者更容易发生LV舒张功能障碍型心肌病;心肌病亚组的cTnI水平更高。RV收缩功能障碍性心肌病亚组的SOFA评分和NT-proBNP水平更高。脓毒症患者发生RV收缩功能障碍显著增加死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/11055516/7f9a7f6a712b/RMHP-17-1015-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/11055516/00e46a65a726/RMHP-17-1015-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/11055516/7f9a7f6a712b/RMHP-17-1015-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/11055516/00e46a65a726/RMHP-17-1015-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/11055516/7f9a7f6a712b/RMHP-17-1015-g0002.jpg

相似文献

1
Types of Septic Cardiomyopathy: Prognosis and Influencing Factors - A Clinical Study.感染性心肌病的类型:预后及影响因素——一项临床研究
Risk Manag Healthc Policy. 2024 Apr 23;17:1015-1025. doi: 10.2147/RMHP.S452803. eCollection 2024.
2
[Elevated plasma histone is an independent risk factor for the development of septic cardiomyopathy].血浆组蛋白升高是脓毒症性心肌病发生的独立危险因素
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Dec;31(12):1457-1461. doi: 10.3760/cma.j.issn.2095-4352.2019.12.005.
3
[Prediction value of plasma histone in prognosis of sepsis patients].[血浆组蛋白对脓毒症患者预后的预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jun;31(6):674-679. doi: 10.3760/cma.j.issn.2095-4352.2019.06.003.
4
Prognostic Significance of Diastolic Dysfunction in Type 2 Diabetes Mellitus Patients With Sepsis and Septic Shock: Insights From a Longitudinal Tertiary Care Study.2型糖尿病合并脓毒症和感染性休克患者舒张功能障碍的预后意义:一项纵向三级医疗研究的见解
Cureus. 2023 Sep 25;15(9):e45894. doi: 10.7759/cureus.45894. eCollection 2023 Sep.
5
N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.N末端前脑钠肽和心肌肌钙蛋白I在重症监护病房老年严重脓毒症或脓毒性休克患者中的预后价值:一项回顾性研究
J Crit Care. 2015 Jun;30(3):654.e9-14. doi: 10.1016/j.jcrc.2014.12.008. Epub 2014 Dec 18.
6
[Study on the relationship between ventricular function parameters obtained by echocardiography and prognosis of patients with sepsis].[超声心动图获得的心室功能参数与脓毒症患者预后的关系研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jul;34(7):740-745. doi: 10.3760/cma.j.cn121430-20210826-01281.
7
Evaluation Value and Clinical Significance of Cardiac Troponin Level and Pediatric Sequential Organ Failure Score in the Definition of Sepsis 3.0 in Critically Ill Children.严重脓毒症 3.0 定义中心肌钙蛋白水平和儿科序贯器官衰竭评分的评估价值及临床意义。
Comput Math Methods Med. 2022 Aug 9;2022:9492178. doi: 10.1155/2022/9492178. eCollection 2022.
8
Analysis of Prognostic Risk Factors of Sepsis Patients With Myocardial Injury: Six-month Survival Outcome.分析心肌损伤脓毒症患者的预后危险因素:6 个月生存结局。
Altern Ther Health Med. 2023 Nov;29(8):744-749.
9
The prognostic value of left ventricular systolic function and cardiac biomarkers in pediatric severe sepsis.左心室收缩功能及心脏生物标志物在儿童严重脓毒症中的预后价值
Medicine (Baltimore). 2019 Mar;98(13):e15070. doi: 10.1097/MD.0000000000015070.
10
[Asymptomatic ischemic heart dysfunction, echocardiographic changes and NT-proBNP during 2-years observation].[两年观察期内无症状性缺血性心脏功能障碍、超声心动图变化及N末端B型利钠肽原]
Przegl Lek. 2014;71(7):378-83.

引用本文的文献

1
The predictive value of SOFA and APSIII scores for 28-day mortality risk in SIMI: a cohort study based on the MIMIC-IV database.序贯器官衰竭评估(SOFA)和急性生理与慢性健康状况评分系统III(APSIII)对脓毒症诱导的心肌损伤(SIMI)患者28天死亡风险的预测价值:一项基于多中心重症医学信息数据库-4(MIMIC-IV)的队列研究
Front Cell Infect Microbiol. 2025 Jul 29;15:1574625. doi: 10.3389/fcimb.2025.1574625. eCollection 2025.
2
Identification of Prognostic Factors for Sepsis or Septic Shock Patients with Cardiac Dysfunction.脓毒症或脓毒性休克合并心功能不全患者预后因素的识别
J Cardiovasc Transl Res. 2025 Jul 5. doi: 10.1007/s12265-025-10645-8.
3
Heparanase inhibitor improves clinical study in patients with septic cardiomyopathy.

本文引用的文献

1
Early Diastolic Peak Velocity of Mitral Valve Annulus and Right Ventricular Systolic Tricuspid Annular Velocity as Predictors in Assessing Prognosis of Patients with Sepsis.二尖瓣环舒张早期峰值速度和右心室收缩期三尖瓣环速度作为评估脓毒症患者预后的预测指标
Risk Manag Healthc Policy. 2023 May 17;16:921-930. doi: 10.2147/RMHP.S407929. eCollection 2023.
2
Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting.脓毒症性心肌病:从病理生理学到临床环境。
Cells. 2022 Sep 11;11(18):2833. doi: 10.3390/cells11182833.
3
Risk factors of postoperative septic cardiomyopathy in perioperative sepsis patients.
硫酸乙酰肝素酶抑制剂改善脓毒症性心肌病患者的临床研究。
Front Med (Lausanne). 2024 Aug 7;11:1429109. doi: 10.3389/fmed.2024.1429109. eCollection 2024.
围手术期脓毒症患者术后感染性心肌病的危险因素。
BMC Anesthesiol. 2022 Jun 22;22(1):193. doi: 10.1186/s12871-022-01714-5.
4
Is diastolic dysfunction a new windsock in the risk stratification of patients with coronary heart disease?舒张功能障碍是冠心病患者风险分层中的一个新风向标吗?
Int J Cardiol. 2022 Jan 1;346:103-104. doi: 10.1016/j.ijcard.2021.11.037. Epub 2021 Nov 17.
5
Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021.执行摘要:拯救脓毒症运动:2021年脓毒症和脓毒性休克管理国际指南。
Crit Care Med. 2021 Nov 1;49(11):1974-1982. doi: 10.1097/CCM.0000000000005357.
6
Pathophysiology of sepsis-induced cardiomyopathy.脓毒症性心肌病的病理生理学。
Nat Rev Cardiol. 2021 Jun;18(6):424-434. doi: 10.1038/s41569-020-00492-2. Epub 2021 Jan 20.
7
Septic Cardiomyopathy: From Basics to Management Choices.脓毒症性心肌病:从基础到治疗选择。
Curr Probl Cardiol. 2021 Apr;46(4):100767. doi: 10.1016/j.cpcardiol.2020.100767. Epub 2020 Dec 11.
8
Elevated plasma histone H4 level predicts increased risk of mortality in patients with sepsis.血浆组蛋白H4水平升高预示脓毒症患者死亡风险增加。
Ann Palliat Med. 2020 May;9(3):1084-1091. doi: 10.21037/apm-20-1011. Epub 2020 May 14.
9
Sepsis-Induced Cardiomyopathy: a Comprehensive Review.脓毒症相关性心肌病:全面综述。
Curr Cardiol Rep. 2020 May 6;22(5):35. doi: 10.1007/s11886-020-01277-2.
10
Elevated Plasma Histone H4 Levels Are an Important Risk Factor in the Development of Septic Cardiomyopathy.血浆组蛋白 H4 水平升高是导致脓毒性心肌病的一个重要危险因素。
Balkan Med J. 2020 Feb 28;37(2):72-78. doi: 10.4274/balkanmedj.galenos.2019.2019.8.40. Epub 2019 Nov 1.